- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05817487
Effects of COP Exercise and HIIT on Vascular Health in Young Overweight Females
April 5, 2023 updated by: Beijing Sport University
Effects of Crossover Point Exercise and High-intensity Interval Training on Vascular Health in Young Overweight Females
The goal of this study is to determine the effects of high-intensity interval training and crossover point exercise training on vascular health in young overweight women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In recent years, improving cardiovascular health through exercise has become a popular research question, however, it is not clear which intensity and modes of exercise bring more benefits.
Crossover point(COP) intensity has great medical potential as a personalized exercise intensity that is based on substrate utilization mode, especially in overweight and obese people.On the other hand, several studies have demonstrated that HIIT is an effective method in improving vascular endothelial dysfunction.
During our study, we evaluated the vascular health changes in young overweight women who received either COP exercise or HIIT exercise for 10 weeks.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China
- Beijing Sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female, 18-30 years old
- Body mass index (BMI) < 28 kg/m2 and ≥ 24 kg/m2
- No exercise habit, and no recent new exercise plan
- No contraindications to exercise
Exclusion Criteria:
- Participates had an orthopedic or other condition that limited participation in daily exercise
- Participates had a history of myocardial infarction, stroke, diabetes mellitus, chronic respiratory disease or cancer
- Participates had smoking or alcohol behavior
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HIIT group
|
Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks.
The training sessions in the HIIT group involved five high-intensity intervals of 4 minutes each (running or walking on a treadmill) at 85% VO2max interspersed with 3 minutes of low-intensity walking.
|
|
Experimental: COP group
|
Participants in both the COP and HIIT groups underwent 30 sessions of exercise performed over 10 weeks.
The COP exercise training sessions involved 45 minutes of continuous exercise at the COP on a treadmill.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
brachial-ankle pulse wave velocity (baPWV)
Time Frame: 10 weeks
|
The change of baPWV before and after intervention
|
10 weeks
|
|
blood pressure
Time Frame: 10 weeks
|
The change of blood pressure before and after intervention
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interleukin 6 (IL-6)
Time Frame: 10 weeks
|
The change of IL-6 level before and after intervention
|
10 weeks
|
|
Homocysteine (HCY)
Time Frame: 10 weeks
|
The change of HCY level before and after intervention
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 18, 2019
Primary Completion (Actual)
July 5, 2019
Study Completion (Actual)
October 25, 2019
Study Registration Dates
First Submitted
April 5, 2023
First Submitted That Met QC Criteria
April 5, 2023
First Posted (Actual)
April 18, 2023
Study Record Updates
Last Update Posted (Actual)
April 18, 2023
Last Update Submitted That Met QC Criteria
April 5, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EOCPEAHITOVHIYOF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Diseases
-
Leiden University Medical CenterRecruitingVascular Disease,PeripheralNetherlands
-
Boston Scientific CorporationRecruitingPeripheral Vascular DiseasesUnited States, Australia, Taiwan, Thailand, Austria, Germany, Canada, France, China, Spain, Poland
-
Midwest Cardiovascular Research FoundationCompletedPeripheral Vascular DiseaseUnited States
-
W.L.Gore & AssociatesActive, not recruitingPeripheral Vascular DiseasesGermany, Netherlands, France, Italy, Spain
-
The Methodist Hospital Research InstituteNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPeripheral Vascular DiseasesUnited States
-
SensomeCompletedPeripheral Vascular DiseaseBelgium
-
Rijnstate HospitalCompletedPeripheral Vascular DiseasesNetherlands
-
AmgenCompletedChorioretinal Vascular DiseaseUnited States
-
Duke UniversityTerminatedRetinal Vascular DiseaseUnited States
-
Terumo Europe N.V.CompletedPeripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular ProcedureBelgium, France, Germany
Clinical Trials on high-intensity interval training (HIIT)
-
Wroclaw University of Health and Sport SciencesActive, not recruitingPhysical Activity | Blood Pressure | Cardiorespiratory Fitness | Adipose Tissue | AdolescentsPoland
-
Université de SherbrookeRecruiting
-
Mayo ClinicActive, not recruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia
-
McMaster UniversityCompleted
-
Chang Gung Memorial HospitalCompletedHeart Failure | Morality | Remodeling, VentricularTaiwan
-
Brock UniversityCompletedCardiovascular Diseases | Metabolic SyndromeCanada
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedKnee OsteoarthritisUnited States
-
Amsterdam UMC, location VUmcRecruitingExercise | Brain Tumor, PrimaryNetherlands